loading page

Oncology care during COVID-19 pandemic in a low middle-income country
  • Amita Trehan,
  • Richa Jain,
  • Deepak Bansal
Amita Trehan
Post Graduate Institute of Medical Education and Research

Corresponding Author:[email protected]

Author Profile
Richa Jain
Postgraduate Institute of Medical Education & Research
Author Profile
Deepak Bansal
Advanced Pediatric Center, Postgraduate Institute of Medical Education and Research
Author Profile


The 2019 novel coronavirus disease (COVID-19) has affected all aspects of life globally and care of children with malignancies is no exception. We are part of a large tertiary care 2000 bedded university hospital in North India. Approximately 450 new malignancies are diagnosed annually, translating to 10 patients per week. About 200 children attend the clinics every week. Additionally, 15-20 walk-in patients are evaluated daily in the daycare. Patients travel from distances as far as 500 km to reach our center.  Merely 20% live within 50 km of the hospital, and approximately 35% reside at a distance exceeding 200 km. Two-third of the patients hail from urban areas and one third belong to rural areas. The majority of families stay in a patient hostel in the hospital premises, and a few rent a flat in the city for the 4-9 months duration of intensive phase of therapy. The Government of India mandated a lockdown on the 24th March 2020 in response to the coronavirus pandemic and the outpatient services of the hospital were closed. The borders with the neighboring states were sealed & vehicular movement curtailed with barring of public transport & suspension of all interstate and intercity travel. The citizens were advised to maintain social distancing. The unit was faced with the formidable challenge of ensuring the well-being of children under our care from a wide geographical spread with minimal access to Pediatric Oncology services in their   hometowns. How did we manage our patients?
09 May 2020Submission Checks Completed
09 May 2020Assigned to Editor
09 May 2020Submitted to Pediatric Blood & Cancer
10 May 2020Review(s) Completed, Editorial Evaluation Pending
10 May 2020Editorial Decision: Revise Minor
10 May 20201st Revision Received
10 May 2020Submission Checks Completed
10 May 2020Assigned to Editor
11 May 2020Review(s) Completed, Editorial Evaluation Pending
11 May 2020Editorial Decision: Accept